2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on nmCRPC: Does the Utilization of Early AR Antagonism Prolong Survival?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Hala Borno
By 2020 ASCO Virtual Direct™ Highlights FEATURING Hala Borno
71 views
August 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn
GU
08:02
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mUC: Can Tumor Microenvironment Biomarkers Help …

Feat. D. Quinn
06:18
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Is Nivo Monotherapy Active in Trea…

Feat. D. Quinn
09:35
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: 1L Pembro + Axitinib vs. Sunitinib…

Feat. D. Quinn
10:31
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Urothelial Cancer: Maintenance Avelumab…

Feat. D. Quinn
09:43
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Delivery of ADT in Advanced Prostate Cancer: Rel…

Feat. H. Borno
08:38
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Molecular Imaging in Prostate Cancer: Is 18F-DCF…

Feat. H. Borno
09:15
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on nmCRPC: Does the Utilization of Early AR Antagon…

Feat. H. Borno